glp 1 agonist muscle loss Using glp-1 receptor agonists for weight reduction in dystrophy patients Weight loss with GLP-1 medicines
Description
J Cardiovasc Pharmacol
10.1016/j.diabet.2021.101223 94 SongG.YangD.WangY.de GraafC.ZhouQ.JiangS.et al (2017)
Cross-Indication Pricing Implications With GLP-1 therapies spanning multiple indications, cross-indication pricing poses a strategic challenge
To date, clinical data have been reported for two dual GIP/GLP-1 receptor agonists
doi: 10.1016/j.neuroscience.2009.05.025 194 ZhangHSongBZhuWLiuLHeXWangZet al
